002004 华邦健康
2024/06 - 中期2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)3.1242.9774.2716.7676.871
总资产报酬率 ROA (%)1.0140.9951.4432.2922.376
投入资产回报率 ROIC (%)1.5181.4932.1283.2723.306

边际利润分析
销售毛利率 (%)36.71739.11440.49438.20140.961
营业利润率 (%)9.4967.99112.43210.72810.986
息税前利润/营业总收入 (%)11.7139.68713.83113.83816.181
净利润/营业总收入 (%)7.1635.8388.5197.4028.229

收益指标分析
经营活动净收益/利润总额(%)99.493128.369103.23881.53271.695
价值变动净收益/利润总额(%)-2.1480.97726.90924.08021.953
营业外收支净额/利润总额(%)-1.466-3.824-1.375-4.089-2.556

偿债能力分析
流动比率 (X)1.0471.0711.0401.0810.922
速动比率 (X)0.8250.8190.8120.8700.755
资产负债率 (%)47.73346.02644.88347.3400.499
带息债务/全部投入资本 (%)49.29247.49945.97648.26149.458
股东权益/带息债务 (%)96.893104.097110.721101.10496.859
股东权益/负债合计 (%)67.07171.45275.62171.07468.346
利息保障倍数 (X)4.9764.8678.8213.9192.959

营运能力分析
应收账款周转天数 (天)55.83153.12058.40862.20066.044
存货周转天数 (天)124.036132.847112.879102.001113.335